New PEG-based formula to treat children's functional constipation and improve taste
Official title: Faculty of Medicine, Chulalongkorn University
Run by Chulalongkorn University · NCT06357897 · Data updated 2026-11-12
This trial will test whether a newly developed PEG-based laxative works as well as the standard PEG and whether children find it tastier for treating functional constipation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Months to 18 Years |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | Chulalongkorn University Academic / other |
| Locations | 1 site (Bangkok) |
| Status | Recruiting |
| Started | May 3, 2024 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | April 2, 2026 |
| Trial ID | NCT06357897 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 6 months to 18 years who meet Rome IV criteria for functional constipation and do not have organic causes, bowel obstruction, interfering medications, or allergies to PEG/stevia are ideal candidates.
✕Probably not a fit
Children with organic causes of constipation (e.g., Hirschsprung disease), suspected GI obstruction, allergy to PEG or stevia, or who cannot adhere to the dosing/visit schedule are unlikely to benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Fifty-two children aged 6 months to 18 years with functional constipation will be randomized to receive either a developed PEG formulation (PEG-Chula) or the standard PEG (Forlax) at 0.5–1 g/kg/day for 56 days with identical sachet packaging to maintain blinding. Families will receive the same counseling on toilet training, fluids, and fiber, and parents will record symptoms, intake, and medication in a logbook. Clinical visits occur on days 7, 14, 28, and 56 to collect symptom data, measure stool and rectal diameter by ultrasound, record side effects, and check compliance. Children with poor medication compliance or excluded organic causes of constipation are removed from analysis.
Why it matters
Potential benefit: If successful, the new PEG formula could make treatment easier for children by improving taste while providing similar relief from constipation.
How similar studies have gone: Standard PEG formulas are well established as effective for pediatric functional constipation, while reformulations to improve palatability are common though this specific PEG-Chula formula appears novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Children will be enrolled in this study when they meet 2 criteria: * Age from 6 months to 18 years old * Children are diagnosed with FC according to ROME IV criteria Exclusion Criteria: Children will be excluded from the study if they meet any of the following criteria: * Having an organic cause of constipation such as anorectal malformations, Hirschsprung disease, myelomeningocele, hypothyroidism, etc. * Suspected GI obstruction * Receiving medication affecting bowel movement * Having a history of allergy to PEG and stevia.
Where it's running
-
Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand Recruiting
Study contacts
- Study coordinator: Duc Long Tran, M.D.
- Email: tdlong@ctump.edu.vn
- Phone: +66916668748
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Core-based movement plus nutrition for stress and metabolic health in overweight women with functional constipation
This study tests whether an 8-week core-based exercise program plus nutritional counseling improves stress, cortisol, and lipid levels in overweight women with functional constipation.
-
BioAmicus Complete for infants with colic, reflux, constipation, or loose stools (0–24 months)
This study will see if the multistrain probiotic BioAmicus Complete can help reduce caregiver‑reported tummy symptoms in infants aged 0–24 months.
-
Ma-Zi-Ren-Wan (MZRW) herbal treatment for constipation in cancer survivors
This will see if the herbal formula Ma-Zi-Ren-Wan (MZRW) helps relieve functional constipation in adult cancer survivors compared with a placebo.
-
Observing functional digestive disorders
This study is collecting health information and samples from people with digestive issues like irritable bowel syndrome to see if it can help find better treatments for them.
-
Non-surgical treatment for women with pelvic organ prolapse and bowel-emptying problems
This will test whether a combined non-surgical program—tibial nerve stimulation, biofeedback, pelvic floor exercises, and diet changes—can improve bowel-emptying symptoms in women with mild-to-moderate pelvic organ prolapse.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.